Campaign promises on North Main, Transit Plus, mental health responses - CBC

Carlos Rodrigo Garibay Rubio1,2, Genta Nakano3, Katsuya Yamori3, Astrid Renneé Peralta Gutiérrez3,4, Silvia Morales Chainé5, Rebeca Robles García We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.

Google is updating how links will be presented in both AI Mode and AI Overviews. The search engine has announced five changes. First, it will display inline links more frequently higher up in response listings. Second, it plans to start testing a section at the top of certain responses with links to official sites about a specific task. Hema Budaraju, VP of Product Management, described five updates in a blog post. Google is also expanding its carousels for timely articles, which highlight a user’s Preferred Sources, to more locations and languages. This week, it started testing creator and publisher names on AI Mode video results that link to Search profiles.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.